Gallic acid prevents nonsteroidal anti-inflammatory drug-induced gastropathy in rat by blocking oxidative stress and apoptosis

Free Radical Biology and Medicine

Volumn 49, Issue 2, 2010, Pages 258-267

  Pal, Chinmay ^a   Bindu, Samik ^a   Dey, Sumanta ^a   Alam, Athar ^a   Goyal, Manish ^a   Iqbal, Mohd Shameel ^a   Maity, Pallab ^a   Adhikari, Susanta S ^b   Bandyopadhyay, Uday ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b UNIVERSITY OF BURDWAN   (India)

Author keywords

Apoptosis; Free radical; Gallic acid; Gastropathy; NSAID; Oxidative stress; Reactive oxygen species

Indexed keywords

CARBONYL DERIVATIVE; CASPASE 9; DICLOFENAC; GALLIC ACID; HYDROGEN; INDOMETACIN; LIPID; MITOCHONDRIAL PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; OXIDOREDUCTASE; SCAVENGER; THIOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DRUG STRUCTURE; ENZYME INHIBITION; IN VITRO STUDY; IN VIVO CULTURE; IN VIVO STUDY; LIPID PEROXIDATION; MITOCHONDRIAL MEMBRANE POTENTIAL; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; PROTEIN DEPLETION; RAT; SIGNAL TRANSDUCTION; STOMACH DISEASE; STOMACH MUCOSA; STRUCTURE ANALYSIS;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; APOPTOSIS; CASPASE 9; CELLS, CULTURED; ENZYME ACTIVATION; GALLIC ACID; GASTRIC MUCOSA; IRON CHELATING AGENTS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MITOCHONDRIA; PROTEIN CARBONYLATION; RATS; RATS, SPRAGUE-DAWLEY; STOMACH DISEASES;

RATTUS;

EID: 77953609415     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2010.04.013     Document Type: Article

References (72)

1. Regula J., Butruk E., Dekkers C.P., de Boer S.Y., Raps D., Simon L., Terjung A., Thomas K.B., Lühmann R., Fischer R. Prevention of NSAID-associated gastrointestinal lesions: a comparison study pantoprazole versus omeprazole. Am. J. Gastroenterol. 2006, 101:1747-1755.
2. Thompson M., Percy J.S. Further experience with indomethacin in the treatment of rheumatic disorders. Br. Med. J. 1966, 1:80-83.
3. Harth M., Bondy D.C. Indomethacin and acetylsalicylic acid in the treatment of osteoarthritis of the hips and knees. Can. Med. Assoc. J. 1969, 101:311-316.
4. Schlansky B., Hwang J.H. Prevention of nonsteroidal anti-inflammatory drug-induced gastropathy. J. Gastroenterol. 2009, 44(Suppl. 19):44-52.
5. Wallace J.L. Pathogenesis of NSAID-induced gastroduodenal mucosal injury. Best Pract. Res. Clin. Gastroenterol. 2001, 15:691-703.
6. Maity P., Bindu S., Dey S., Goyal M., Alam A., Pal C., Mitra K., Bandyopadhyay U. Indomethacin, a non-steroidal anti-inflammatory drug, develops gastropathy by inducing reactive oxygen species-mediated mitochondrial pathology and associated apoptosis in gastric mucosa: a novel role of mitochondrial aconitase oxidation. J. Biol. Chem. 2009, 284:3058-3068.
7. Maity P., Biswas K., Roy S., Banerjee R.K., Bandyopadhyay U. Smoking and the pathogenesis of gastroduodenal ulcer-recent mechanistic update. Mol. Cell. Biochem. 2003, 253:329-338.
8. Becker J.C., Domschke W., Pohle T. Current approaches to prevent NSAID-induced gastropathy-COX selectivity and beyond. Br. J. Clin. Pharmacol. 2004, 58:587-600.
9. Maity P., Bindu S., Dey S., Goyal M., Alam A., Pal C., Reiter R., Bandyopadhyay U. Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis. J. Pineal Res. 2009, 46:314-323.
10. Maity P., Bindu S., Choubey V., Alam A., Mitra K., Goyal M., Dey S., Guha M., Pal C., Bandyopadhyay U. Lansoprazole protects and heals gastric mucosa from non-steroidal anti-inflammatory drug (NSAID)-induced gastropathy by inhibiting mitochondrial as well as Fas-mediated death pathways with concurrent induction of mucosal cell renewal. J. Biol. Chem. 2008, 283:14391-14401.
11. +-ATPase, oxidative damage and apoptosis. Inflammopharmacol 2004, 12:153-176.
12. Biswas K., Bandyopadhyay U., Chattopadhyay I., Varadaraj A., Ali E., Banerjee R.K. A novel antioxidant and antiapoptotic role of omeprazole to block gastric ulcer through scavenging of hydroxyl radical. J. Biol. Chem. 2003, 278:10993-11001.
13. Tani S., Matsuda K., Tanaka T. Induction of apoptosis in cultured rat gastric epithelial cells by ipriflavone: comparison with indomethacin. Biol. Pharm. Bull. 2004, 27:647-651.
14. Kusuhara H., Matsuyuki H., Matsuura M., Imayoshi T., Okumoto T., Matsui H. Induction of apoptotic DNA fragmentation by nonsteroidal anti-inflammatory drugs in cultured rat gastric mucosal cells. Eur. J. Pharmacol. 1998, 360:273-280.
15. Somasundaram S., Simpson R., Rafi S., Shergill J.K., Bjarnason I., Wrigglesworth J. 2, 4-Diamino-6-hydroxy pyrimidine inhibits NSAIDs induced nitrosyl-complex EPR signals and ulcer in rat jejunum. BMC Gastroenterol. 2002, 2:8.
16. Davies A.A., Lah J.J., Levey A.I. Neurobiology of Alzheimer's disease. The American Psychiatric Publishing Textbook of Psychopharmacology 2009, 987-1006. Am. Psychiatric Pub, Arlington, VA. 4th ed. A.F. Schatzberg, C.B. Nemeroff (Eds.).
17. Orrenius S., Gogvadze V., Zhivotovsky B. Mitochondrial oxidative stress: implications for cell death. Annu. Rev. Pharmacol. Toxicol. 2007, 47:143-183.
18. Fariss M.W., Chan C.B., Patel M., Van Houten B., Orrenius S. Role of mitochondria in toxic oxidative stress. Mol. Interv. 2005, 5:94-111.
19. Tiwari B.S., Belenghi B., Levine A. Oxidative stress increased respiration and generation of reactive oxygen species, resulting in ATP depletion, opening of mitochondrial permeability transition, and programmed cell death. Plant Physiol. 2002, 128:1271-1281.
20. Chattopadhyay I., Bandyopadhyay U., Biswas K., Maity P., Banerjee R.K. Indomethacin inactivates gastric peroxidase to induce reactive-oxygen-mediated gastric mucosal injury and curcumin protects it by preventing peroxidase inactivation and scavenging reactive oxygen. Free Radic. Biol. Med. 2006, 40:1397-1408.
21. Kim S.H., Jun C.D., Suk K., Choi B.J., Lim H., Park S., Lee S.H., Shin H.Y., Kim D.K., Shin T.Y. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol. Sci. 2006, 91:123-131.
22. Chakraborty A., Ferk F., Simic T., Brantner A., Dusinska M., Kundi M., Hoelzl C., Nersesyan A., Knasmuller S. DNA-protective effects of sumach (Rhus coriaria L.), a common spice: results of human and animal studies. Mutat. Res. 2009, 661:10-17.
23. Shahrzad S., Aoyagi K., Winter A., Koyama A., Bitsch I. Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J. Nutr. 2001, 131:1207-1210.
24. Atkinson B.L., Blackman A.J., Faber H. The degradation of the natural pyrethrins in crop storage. J. Agric. Food Chem. 2004, 52:280-287.
25. Wu N., Zu Y., Fu Y., Kong Y., Zhao J., Li X., Li J., Wink M., Efferth T. Antioxidant activities and xanthine oxidase inhibitory effects of extracts and main polyphenolic compounds obtained from Geranium sibiricum L. J. Agric. Food Chem. 2010, 58:4737-4743.
26. Crescente M., Jessen G., Momi S., Holtje H.D., Gresele P., Cerletti C., de Gaetano G. Interactions of gallic acid, resveratrol, quercetin and aspirin at the platelet cyclooxygenase-1 level: functional and modelling studies. Thromb. Haemostasis 2009, 102:336-346.
27. Uozaki M., Yamasaki H., Katsuyama Y., Higuchi M., Higuti T., Koyama A.H. Antiviral effect of octyl gallate against DNA and RNA viruses. Antiviral Res. 2007, 73:85-91.
28. Crane J.T., Lindsay M.D.S. An attempt to prevent histamine-induced ulcers in guinea pigs with Benadryl. Am. J. Dig. Dis. 1947, 14:56-57.
29. Zhang X., Tajima K., Kageyama K., Kyoi T. Irsogladine maleate suppresses indomethacin-induced elevation of proinflammatory cytokines and gastric injury in rats. World J. Gastroenterol. 2008, 14:4784-4790.
30. Bhattacharya S., Chatterjee S., Bauri A., Bandivdeker A.H., Chattopadhyay S., Bandyopadhyay S.K., Poduval T.B. Immunopharmacological basis of the healing of indomethacin-induced gastric mucosal damage in rats by the constituents of Phyllanthus emblica. Curr. Sci. 2007, 93:47-53.
31. Jainu M., Shyamala Devi C.S. Attenuation of neutrophil infiltration and proinflammatory cytokines by Cissus quadrangularis: a possible prevention against gastric ulcerogenesis. J. Herb. Pharmacother. 2005, 5:33-42.
32. Koizumi S., Odashima M., Otaka M., Jin M., Linden J., Watanabe S., Ohnishi H. Attenuation of gastric mucosal inflammation induced by indomethacin through activation of the A2A adenosine receptor in rats. J. Gastroenterol. 2009, 44:419-425.
33. Li T., Zhang X., Zhao X. Powerful protective effects of gallic acid and tea polyphenols on human hepatocytes injury induced by hydrogen peroxide or carbon tetrachloride in vitro. J. Med. Plant Res. 2010, 4:247-254.
34. Sameermahmood Z., L.R., Saravanan T., Vaidya A., Mohan V., Balasubramanyam M. Gallic acid protects RINm5F b-cells from glucolipotoxicity by its antiapoptotic and insulin-secretagogue actions. Phytother. Res. 2010, 24:S83-S94.
35. Andjelkovića M.C., Van J., Meulenaer B.D., Depaemelaere G., Socaciu C., Verloo M., Verhe R. Iron-chelation properties of phenolic acids bearing catechol and galloyl groups. Food Chem. 2006, 98:23-31.
36. Eid Fazary A.M.T., Ju Y.-H. Iron complexation studies of gallic acid. J. Chem. Eng. Data 2009, 54:35-42.
37. +-ATPase inhibition and scavenging of hydroxyl radical. Life Sci. 2002, 71:2845-2865.
38. Guha M., Maity P., Choubey V., Mitra K., Reiter R.J., Bandyopadhyay U. Melatonin inhibits free radical-mediated mitochondrial-dependent hepatocyte apoptosis and liver damage induced during malarial infection. J. Pineal Res. 2007, 43:372-381.
39. Ben Farhat M., Jordan M.J., Chaouech-Hamada R., Landoulsi A., Sotomayor J.A. Variations in essential oil, phenolic compounds, and antioxidant activity of Tunisian cultivated Salvia officinalis L. J. Agric. Food Chem. 2009, 57:10349-10356.
40. Han J., Hai L., Chen P., Mirban S. Nurdana; Liu, J. [Determination of antioxidative activity of different fractions of Xinjiang red raspberry fruits extract]. Wei Sheng Yan Jiu 2009, 38:596-598.
41. Firuzi O., Lacanna A., Petrucci R., Marrosu G., Saso L. Evaluation of the antioxidant activity of flavonoids by "ferric reducing antioxidant power" assay and cyclic voltammetry. Biochim. Biophys. Acta 2005, 1721:174-184.
42. Terano A., Ivey K.J., Stachura J., Sekhon S., Hosojima H., McKenzie W.N., Krause W.J., Wyche J.H. Cell culture of rat gastric fundic mucosa. Gastroenterology 1982, 83:1280-1291.
43. Guha M., Kumar S., Choubey V., Maity P., Bandyopadhyay U. Apoptosis in liver during malaria: role of oxidative stress and implication of mitochondrial pathway. FASEB J. 2006, 20:1224-1226.
44. Dey S., Guha M., Alam A., Goyal M., Bindu S., Pal C., Maity P., Mitra K., Bandyopadhyay U. Malarial infection develops mitochondrial pathology and mitochondrial oxidative stress to promote hepatocyte apoptosis. Free Radic. Biol. Med. 2009, 46:271-281.
45. Wang X., Mori T., Sumii T., Lo E.H. Hemoglobin-induced cytotoxicity in rat cerebral cortical neurons: caspase activation and oxidative stress. Stroke 2002, 33:1882-1888.
46. Liu J., Yu Z., Guo S., Lee S.R., Xing C., Zhang C., Gao Y., Nicholls D.G., Lo E.H., Wang X. Effects of neuroglobin overexpression on mitochondrial function and oxidative stress following hypoxia/reoxygenation in cultured neurons. J. Neurosci. Res. 2009, 87:164-170.
47. Estimating the safe starting dose in clinical trials for therapeutics in adult healthy volunteers 2002, Center for Drug Evaluation and Research, Center for Biologics Evaluation and ResearchCenter for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, MD.
48. Manach C., Williamson G., Morand C., Scalbert A., Remesy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am. J. Clin. Nutr. 2005, 81:230S-242S.
49. Firuzi O., Mladenka P., Petrucci R., Marrosu G., Saso L. Hypochlorite scavenging activity of flavonoids. J. Pharm. Pharmacol. 2004, 56:801-807.
50. Ioku K., Tsushida T., Takei Y., Nakatani N., Terao J. Antioxidative activity of quercetin and quercetin monoglucosides in solution and phospholipid bilayers. Biochim. Biophys. Acta 1995, 1234:99-104.
51. Haenen G.R., Paquay J.B., Korthouwer R.E., Bast A. Peroxynitrite scavenging by flavonoids. Biochem. Biophys. Res. Commun. 1997, 236:591-593.
52. •-. Free Radic. Biol. Med. 1991, 11:1-8.
53. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.A., Morio B., Vidal H., Rieusset J. Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. J. Clin. Invest. 2008, 118:789-800.
54. Wei Y., Clark S.E., Thyfault J.P., Uptergrove G.M., Li W., Whaley-Connell A.T., Ferrario C.M., Sowers J.R., Ibdah J.A. Oxidative stress-mediated mitochondrial dysfunction contributes to angiotensin II-induced nonalcoholic fatty liver disease in transgenic Ren2 rats. Am. J. Pathol. 2009, 174:1329-1337.
55. Szabo I., Tarnawski A.S. Apoptosis in the gastric mucosa: molecular mechanisms, basic and clinical implications. J. Physiol. Pharmacol. 2000, 51:3-15.
56. Leung A.M., Redlak M.J., Miller T.A. Oxygen radical induced gastric mucosal cell death: apoptosis or necrosis?. Dig. Dis. Sci. 2008, 53:2429-2435.
57. Fujii Y., Matsura T., Kai M., Matsui H., Kawasaki H., Yamada K. Mitochondrial cytochrome c release and caspase-3-like protease activation during indomethacin-induced apoptosis in rat gastric mucosal cells. Proc. Soc. Exp. Biol. Med. 2000, 224:102-108.
58. Salucci M., Stivala L.A., Maiani G., Bugianesi R., Vannini V. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br. J. Cancer 2002, 86:1645-1651.
59. Allan L.A., Clarke P.R. Apoptosis and autophagy: regulation of caspase-9 by phosphorylation. FEBS J. 2009, 276:6063-6073.
60. Saikumar P., Mikhailova M., Pandeswara S.L. Regulation of caspase-9 activity by differential binding to the apoptosome complex. Front. Biosci. 2007, 12:3343-3354.
61. Kroemer G., Galluzzi L., Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 2007, 87:99-163.
62. Mukherjee S. Diarrhea associated with lansoprazole. J. Gastroenterol. Hepatol. 2003, 18:602-603.
63. Umeno J., Matsumoto T., Nakamura S., Jo Y., Yada S., Hirakawa K., Yoshimura R., Yamagata H., Kudo T., Hirano A., Gushima M., Yao T., Nakashima Y., Iida M. Linear mucosal defect may be characteristic of lansoprazole-associated collagenous colitis. Gastrointest. Endosc. 2008, 67:1185-1191.
64. Yusuke H., Jun T., Naotaka M., Yuichi T., Yutaka E., Kazuaki I. Lansoprazole-associated collagenous colitis: unique presentation, similar to ischemic colitis. Endoscopy 2009, 41(Suppl. 2):E281-282.
65. Fort F.L., Miyajima H., Ando T., Suzuki T., Yamamoto M., Hamashima T., Sato S., Kitazaki T., Mahony M.C., Hodgen G.D. Mechanism for species-specific induction of Leydig cell tumors in rats by lansoprazole. Fundam. Appl. Toxicol. 1995, 26:191-202.
66. Panting K.J., Pinto M., Ellison J. Lansoprazole-induced subacute cutaneous lupus erythematosus. Clin. Exp. Dermatol. 2009, 34:733-734.
67. Clark D.W., Strandell J. Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors?. Eur. J. Clin. Pharmacol. 2006, 62:473-479.
68. Jose J., Saravu K., Khera K., Jimmy B., Shastry B.A. Acute interstitial nephritis related to lansoprazole administration. J. Pak. Med. Assoc. 2008, 58:206-207.
69. Gonzalez P., Soriano V., Lopez P., Niveiro E. Anaphylaxis to proton pump inhibitors. Allergol. Immunopathol. (Madrid) 2002, 30:342-343.
70. Dial S., Delaney J.A., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294:2989-2995.
71. Laheij R.J., Sturkenboom M.C., Hassing R.J., Dieleman J., Stricker B.H., Jansen J.B. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. JAMA 2004, 292:1955-1960.
72. Rajalakshmi K., Devaraj H. Niranjali Devaraj, S. Assessment of the no-observed-adverse-effect level (NOAEL) of gallic acid in mice. Food Chem. Toxicol. 2001, 39:919-922.